Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
General Director of PJSC “FITOFARM” Maryana Martynchuk and her team paid a working visit to partners from Turkey – the company MEKSMAR. As part of the implementation of a new…